Analysts Skeptical About Ability Of Korean Government To Draw Investors To Risky R&D Fund
This article was originally published in PharmAsia News
SEOUL - Investors and analysts are voicing skepticism about the Korean government's ability to successfully draw enough investors into a KRW2 trillion ($1.7 billion) R&D fund to help local companies develop innovative new drugs
You may also be interested in...
SEOUL - South Korea's Minister of Health, Welfare and Family Affairs Jeon Jae-hee has issued a warning that the ministry might enlist a special state prosecutor to fight the widespread practice of pharmaceutical companies giving kickbacks to doctors
SEOUL - As part of its effort to root out illegal rebates, the Ministry for Health, Welfare and Family Affairs said it would launch a new "drug-pricing system" in October aimed at compensating hospitals that buy drugs at lower prices than their government-set maximum prices
SEOUL - The Korean government is moving to create a KRW2 trillion ($1.7 billion) research and development fund to help local Korean pharma companies develop globally competitive new drugs